TrialBMC medicine2024

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study.

Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.